CIK 0000744218 · Large accelerated filer
Celldex Therapeutics, Inc.
Sign in to watch- Ticker
- CLDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133191702
- Phone
- 908-200-7500
- Business address
- 53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
- Former names
- AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- S-8 Other Securities Offered to Employees in Benefit Plans
- CT ORDER Other Confidential Order
- CT ORDER Other Confidential Order
- EFFECT Other Notice of Effectiveness
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- EFFECT Other Notice of Effectiveness
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- CT ORDER Other Confidential Order
- CT ORDER Other Confidential Order
- CT ORDER Other Confidential Order
- S-8 Other Securities Offered to Employees in Benefit Plans
- NT 10-Q Other NT 10-Q
- NT 10-K Other NT 10-K
- 8-A12G/A Other 8-A12G/A
- EFFECT Other Notice of Effectiveness
- 8-A12G/A Other 8-A12G/A
Page 3 of 4 · 75 filings